ODDB.org: Open Drug Database

Irinotecan Sandoz 300 mg/15 ml, Infusionskonzentrat - Durchstechflasche(n)

Swissmedic Key	59438015	Registration Holder	Sandoz Pharmaceuticals AG
Name	Irinotecan Sandoz 300 mg/15 ml, Infusionskonzentrat	Date of registration	04.12.2009
		Introduction of Sequence	04.12.2009
ATC-Classification	Irinotecan (L01XX19)	Revision date
WHO	WHO-DDD	Valid until	03.12.2019
Index Therapeuticus (BSV)	07.16.10.	Show package size	Durchstechflasche(n)
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	294.88
Deductible	k.A.	Consumer price	354.90
Feedback	FB
GTIN	7680594380158	Medication Code	Synthetika human
Pharmacode		Disponibility

Composition

irinotecani hydrochloridum trihydricum 300 mg, sorbitolum, acidum lacticum, aqua ad iniectabilia q.s. ad solutionem pro 15 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	300mg / 15ml

Source

Data was imported : 04.12.2014 Swissmedic Registration : 59438 Sequence : 04 Product name : Irinotecan Sandoz 300 mg/15 ml, Infusionskonzentrat Registration owner: : Sandoz Pharmaceuticals AG Product group : Index Therapeuticus (BSV) : 07.16.1. Medication Code : Synthetika human Date of registration : 04.12.2009 Valid until : 03.12.2019 Package number : 015 Show package size : 1 Commercial Form/Unit : Durchstechflasche(n) Swissmedic categorie. : A Active Agents : irinotecani hydrochloridum trihydricum Composition : irinotecani hydrochloridum trihydricum 300 mg, sorbitolum, acidum lacticum, aqua ad iniectabilia q.s. ad solutionem pro 15 ml.

2025	©ywesee GmbH